J & J; buys $1B Elan Stake, Gains Alzheimer’s R

July 1, 2009

126

Johnson & Johnson has agreed to pay $1 billion for an 18.4% stake in Irish drugmaker Elan Corp, and will acquire most of the rights to Elan’s portfolio of experimental drugs to treat Alzheimer’s disease.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

California Misses Budget Deadline, Readies “IOUs”

Job Losses Spike in June, Dampen Recovery Hopes

staff-author

J & J; buys $1B Elan Stake, Gains Alzheimer’s R

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Indie Semi 1Q Revenue in Line with Expectations

CareTrust Boosts Guidance as FFO Climbs

El Pollo Loco Updates 2026 Guidance on 5.8% Same-store Sales Increase in Q1

Related Articles

Indie Semi 1Q Revenue in Line with Expectations

CareTrust Boosts Guidance as FFO Climbs

El Pollo Loco Updates 2026 Guidance on 5.8% Same-store Sales Increase in Q1

Xponential Fitness Posts 21% Drop in Q1 Revenue

Clean Energy Fuels Tops Analysts’ Revenue Estimates

Advertise With Us

About Us

Subscriber Links

Other Journals